SCHEMBL2950550

SCHEMBL2950550

CS(=O)(=O)N1CCCC(n2cnc3c(N)nc(N)nc32)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 1/20 0.50
NFKB1 P19838 1/20 0.50
THPO P40225 1/20 0.50
BLM P54132 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
ADORA2A P29274 4/20 0.43
PI4KA P42356 3/20 0.43
PI4K2B Q8TCG2 3/20 0.43
PI4K2A Q9BTU6 3/20 0.43
PI4KB Q9UBF8 3/20 0.43
ADORA3 P0DMS8 2/20 0.43
ADORA1 P30542 2/20 0.43
ADORA2B P29275 1/20 0.43
AHCY P23526 1/20 0.41
CDK1 P06493 2/20 0.39
CCNB1 P14635 2/20 0.39
CCNE1 P24864 2/20 0.39
CDK2 P24941 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2948868 0.87 CYP1A2 (0.53) CYP1A2CYP3A4NFKB1THPOBLM
Sulfuric Acid SCHEMBL9424495 0.80 CYP1A2 (0.63) CYP1A2CYP3A4NFKB1THPOBLM
SCHEMBL17352601 0.79 ADORA2A (0.65) CYP1A2CYP3A4NFKB1THPOBLM
SCHEMBL2954550 0.78 ADORA2A (0.66) CYP1A2CYP3A4NFKB1THPOBLM
SCHEMBL15941621 0.77 ADORA2A (0.63) CYP1A2CYP3A4NFKB1THPOBLM
SCHEMBL11360552 0.73 CYP1A2 (0.60) CYP1A2CYP3A4NFKB1THPOBLM
SCHEMBL2953211 0.72 ADORA2A (0.48) CYP1A2CYP3A4NFKB1THPOBLM
SCHEMBL29444625 0.72 ADORA2A (0.48) CYP1A2CYP3A4NFKB1THPOBLM
SCHEMBL2946285 0.71 PDE4B (0.46) SMN1; SMN2ADORA2APIK3R1PIK3CA
SCHEMBL2952924 0.71 ADORA2A (0.51) CYP1A2CYP3A4NFKB1THPOBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010111406-A2 COMPOUNDS AND THERAPEUTIC USES THEREOF MYRIAD PHARMACEUTICALS, INC. (US) 2010-09-30 WO claimed